Join our Community
Support ToI and remove all ads
Learn more
search
Moderna
Illustrative: The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection, May 4, 2020. (University of Maryland School of Medicine via AP)
October 19, 2020, 4:31 am
Pfizer begins manufacturing COVID-19 vaccines ahead of expected approval
Pharmaceutical giant has signed an agreement with US government to produce millions of doses even before they are deemed safe and effective
By TOI staff and Agencies
Illustrative: The first patient enrolled in Pfizer's COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection, May 4, 2020. (University of Maryland School of Medicine via AP)
October 16, 2020, 4:38 pm
Pfizer to seek emergency approval for COVID vaccine next month
Pharmaceutical giant says if safety data from trials, expected about 2 weeks after US elections, is positive, it will go ahead with request for ’emergency use authorization’
By AFP
A nurse gives a volunteer an injection as part of a study of a possible COVID-19 vaccine, developed by the US National Institutes of Health and Moderna Inc., in Binghamton, New York, July 27, 2020. (Hans Pennink/AP)
October 1, 2020, 11:32 pm
Israeli vaccine candidate reportedly set to begin human trials next week
Shot developed by Defense Ministry’s Institute for Biological Research still far from wider phase 3 trials; Moderna says its vaccine will not be ready before US election
By TOI staff and Agencies
Laboratory technicians work at the mAbxience biopharmaceutical company on an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca in Garin, Argentina, August 14, 2020. (Natacha Pisarenko/AP)
September 1, 2020, 10:03 pm
Third coronavirus vaccine reaches major hurdle of final US testing
AstraZeneca treatment to begin trials on tens of thousands; US advisory panel releases draft plan for rationing a successful vaccine, with healthcare workers first in line
By LAURAN NEERGAARD and Carla K. Johnson
Illustrative: In this March 16, 2020 file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. (AP Photo/Ted S. Warren, File)
July 27, 2020, 4:27 pm
US virus vaccine put to final test in thousands of volunteers
Shot developed by NIH and Moderna to be tried on 30,000 people in coming months, with Israel among countries rooting for its success
By AP and TOI staff
A syringe injects an illustrated representation of COVID-19, the disease caused by the novel coronavirus, in Paris, on May 18, 2020. (JOEL SAGET/AFP)
July 19, 2020, 5:55 pm
Report: Israel could end up with coronavirus vaccine — but not enough syringes
Deal for inoculations with US biotech firm Moderna said to not include means to inject vaccine; official warns mass purchase of syringes is vital
By TOI staff
A subject receives a shot in the first-stage safety study clinical trial of a potential vaccine by Moderna for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle, March 16, 2020. (AP/Ted S. Warren, File)
July 15, 2020, 4:40 am
Moderna COVID-19 vaccine to enter final stage trials on July 27
Vaccine shown to provide immune boost in 45 volunteers; ‘No matter how you slice this, this is good news,’ says Dr. Anthony Fauci, US government’s top infectious disease expert
By LAURAN NEERGAARD
A person is injected as part of the first human trials in the UK to test a potential coronavirus vaccine, taken by Oxford University in England, on April 23, 2020. (Screenshot/Oxford University Pool via AP)
June 16, 2020, 2:43 pm
UK begins trial of latest vaccine candidate for coronavirus
British government says 300 healthy people will be immunized with 2 doses of experimental shot developed at Imperial College London, which has been backed by official funding
By Agencies and TOI staff
An entrance to a Moderna, Inc., building, May 18, 2020, in Cambridge, Massachusetts. (AP Photo/Bill Sikes)
June 16, 2020, 11:03 am
Israel said to ink deal with Moderna for potential purchase of COVID-19 vaccine
No details published, but Health Ministry source says no action now would mean waiting a year or more once vaccine is available
By TOI staff and Agencies
In this March 16, 2020, file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)
June 15, 2020, 1:41 am
Israel said near to deal with Moderna to supply experimental coronavirus vaccine
Report comes as countries scramble to ensure they will be among first to receive vaccines, if and when they become available; US biotech company to begin Phase 3 trials next month
By TOI staff and Agencies
An entrance to a Moderna, Inc., building, May 18, 2020, in Cambridge, Massachusetts. (AP Photo/Bill Sikes)
May 28, 2020, 3:21 am
Amid virus vaccine hopes, Moderna top execs said to have sold millions in stocks
US biotech firm’s shares soared when it claimed progress in trials; analysts say sales, including by Israeli chief medical officer, are legal but undermine faith in company
By TOI staff and Agencies
In this March 16, 2020, file photo, a pharmacist gives Jennifer Haller, left, the first shot in the first-stage safety study clinical trial of a potential vaccine for COVID-19, the disease caused by the new coronavirus, at the Kaiser Permanente Washington Health Research Institute in Seattle. The vaccine by Cambridge, Massachusetts-based Moderna Inc., generated antibodies similar to those seen in people who have recovered from COVID-19 in a study volunteers who were given either a low or medium dose. (AP Photo/Ted S. Warren, File)
May 18, 2020, 9:04 pm
Moderna’s Israeli top medical officer: We’ve shown today that our vaccine works
US biotech firm’s shares soar as it claims tests of first volunteers show its vaccine candidate produces immune response, ‘has potential to prevent COVID-19’; Phase 3 tests in July
By TOI staff and Agencies
Load More
Is our work important
to you?

Does The Times of Israel give you valuable insight into Israel and the Jewish world?
If so, please join The Times of Israel Community.
For as little as $6/month, you will:

  • Support our independent journalism;
  • Enjoy an ad-free experience on the ToI site, apps and emails; and
  • Unlock exclusive content shared only with the ToI Community, like our new Behind the Headlines interview series with thought leaders, and weekly letters from founding editor David Horovitz.
Join the times of israel community Join our community Already a member? Sign in to stop seeing this